Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaXinhua Wang, Mingzhi Zhang, Liqun Zou et al.|JAMA Oncology|2022Cited by 61
Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patientsZhi‐Yuan Zhou, Mingzhi Zhang, Xiang Li et al.|Annals of Hematology|2014Cited by 52
Lymphoma associated hemophagocytic syndrome: A single‑center retrospective studyYu Chang, Mingzhi Zhang, Meng Cui et al.|Oncology Letters|2018Cited by 43
Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphomaZhi‐Yuan Zhou, Mingzhi Zhang, Lei Zhang et al.|Annals of Hematology|2021Cited by 19
Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149Lei Zhang, Mingzhi Zhang, Jia Sisi et al.|Oncotarget|2016Cited by 19